Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 22Adamax literatureeuropepmc · Observational2026

Autonomic Signature-Driven Anesthesia Depth Monitoring with Biomimetic Wearable ECG and Knowledge Graph-Augmented Deep Networks.

The study presents a wearable ECG-based system that achieved 98.18% accuracy in monitoring anesthesia depth, but the clinical implications of this finding remain unclear.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the adamax corpus
5
Preclinical
16
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study measured the accuracy of a wearable ECG-based framework for monitoring anesthesia depth in 110 patients. The system achieved a test accuracy of 98.18% in distinguishing between awake and deep sleep anesthesia states. No therapeutic claims are made.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
98.18% test accuracy in distinguishing between awake and deep sleep anesthesia states.2026

Abstract

The authors’ words, as europepmc supplied them

Considerable efforts have been devoted to accurately monitoring the depth of anesthesia to ensure patient safety during surgery. Traditional approaches typically rely on electroencephalogram (EEG)-based indices, such as the Bispectral Index (BIS), which require specialized equipment. In contrast, electrocardiogram (ECG) signals are widely available in clinical settings and can be conveniently acquired via wearable devices, while also exhibiting strong responsiveness to anesthetic agents. Inspired by biomimetic physiological regulation mechanisms, this study proposes a wearable-compatible ECG-based framework for depth-of-anesthesia detection that leverages autonomic nervous system characteristics and a knowledge graph-enhanced graph convolutional network (GCN). ECG recordings from 110 patients were preprocessed, and 20 anesthesia-related features were extracted, spanning morphological, statistical, spectral, heart rate variability (HRV), and entropy-based descriptors; feature selection methods identified 13 discriminative features. A patient-level knowledge graph was first constructed using the 88 training patients (1760 nodes), and test patient nodes were incorporated only after training was complete for inductive inference. Experimental results demonstrate that the proposed deep knowledge GCN achieves a test accuracy of 98.18% in distinguishing between awake and deep sleep anesthesia states, indicating that biomimetic, wearable-compatible ECG analysis combined with knowledge graph learning holds strong potential as a cost-effective alternative to traditional EEG-based anesthesia monitoring systems.

Background

This paper addresses the clinical need for accurate monitoring of anesthesia depth, which is crucial for patient safety during surgical procedures. Prior research has indicated that traditional monitoring methods may not adequately reflect the autonomic nervous system's state. This study aims to enhance monitoring accuracy using advanced machine learning techniques and wearable technology.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the Adamax corpus

CA peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia.Nature medicine · 2003 · more than 90% reduction in lesion volume at 14 d post-occlusion in adult miceAnimalBEffects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.JAMA · 2009 · 53.8% decrease in [(11)C]cocaine binding potential in caudate, 95% CI, 43.9% to 63.6%; P < .001HumanAMagnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.Lancet (London, England) · 2012 · Risk ratio [RR] 1.03, 95% CI 0.85-1.25.HumanBPrevalence, knowledge, attitudes, and practices regarding cognitive enhancer use in a convenience sample of university students in Syria: a cross-sectional study.Annals of medicine · 2026 · n=707 · 14.6% (103/707) reported lifetime CE use.HumanCMgSO<sub>4</sub> alleviates anxiety-like behaviours in mice after traumatic brain injury by inhibiting astrocytic TRPM7 in the amygdala.Journal of psychiatric research · 2026 · Not reported in abstract.AnimalCLactoferrin-modified MSC-derived extracellular vesicles facilitate BBB penetration and enhance gastrodin-induced neuroprotection in Parkinson's disease: involvement of mitophagy.International journal of pharmaceutics: X · 2026 · Achieved a brain Gas concentration of 10.34 ± 2.7 ng/g in PD mice versus undetectable levels for free Gas.Animal